ANDREOLI, Michael T.; PINNOLIS, Michael; KIESER, Troy; SUN, Jennifer; ANDREOLI, Christopher M. Feasibility and efficacy of a mass switch from ranibizumab (Lucentis) to bevacizumab (Avastin) for treatment of neovascular age-related macular degeneration. Digital Journal of Ophthalmology, Boston, Massachusetts, USA, v. 21, n. 3, p. 29–34, 2015. DOI: 10.5693/djo.01.2015.04.002. Disponível em: https://djo.harvard.edu/index.php/djo/article/view/380. Acesso em: 20 nov. 2026.